The significant reduction of other chemotactic proteins, such as IP10, MCP1 and RANTES, which have been shown to be associated with the severity of COVID-19 infection in patients, will prevent the attraction of inflammatory immune cells to the sites of infection [18, 19]. This evidence concerns the gene CCL5 and infection.